It is, but the CAGR is not as good as Adapt. You see, for every infusion contract WP has to add staff (like the BME for Adelaide Hospital). Once we are well and truely standing on our feet with Adapt, I would imagine it would be sold off to concentrate on Adapt and not have the staff overheads.
W
Expecting what, when?, page-144
-
- There are more pages in this discussion • 145 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.50 |
Change
0.000(0.00%) |
Mkt cap ! $243.1M | |||
| Open | High | Low | Value | Volume |
| $11.50 | $11.50 | $11.00 | $344.4K | 30.43K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $11.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.50 | 4417 | 1 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |